The male germ cell-specific fatty acid-binding protein 9 (FABP9/PERF15) is the major component of the murine sperm perforatorium and perinuclear theca. Based on its cytoskeletal association and sequence homology to myelin P2 (FABP8), it has been suggested that FABP9 tethers sperm membranes to the underlying cytoskeleton. Furthermore, its upregulation in apoptotic testicular germ cells and its increased phosphorylation status during capacitation suggested multiple important functions for FABP9. Therefore, we investigated specific functions for FABP9 by means of targeted gene disruption in mice. FABP9
Introduction
Mammalian sperm are highly polarized cells with specialized functions restricted to specific regions (Travis and Kopf, 2002) . We have previously shown that the plasma membrane overlying the acrosome (APM) is a large domain greatly enriched in sterols and the sphingolipid, G M1 , in comparison with the post-acrosomal plasma membrane (PAPM) (Selvaraj et al., 2006) . We have also demonstrated that the APM domain is not uniform, but rather contains both membrane raft and non-raft micro-domains of varying compositions; we found no evidence of raft micro-domains in the PAPM Selvaraj et al., 2009 ). The physiological significance of raft segregation to the APM domain is suggested by the functional requirement for sterol efflux in order for sperm to become fertilization competent through the process known as "capacitation" (Austin, 1951 (Austin, , 1952 Chang, 1951; Davis, 1976; Visconti et al., 1999) . Our investigations of the mechanism behind the maintenance of this unique micron-scale membrane segregation pointed to membrane interactions with underlying cytoskeletal elements (Selvaraj et al., 2006) . This mechanism would be consistent with a membrane compartmentation model of domain segregation (Kusumi and Sako, 1996) , but would exist on a larger scale.
On examination of the structural components of the mature sperm head, it has been shown that the perinuclear theca (a dense cytoskeletal network) closely apposes the different membranes of the sperm head (Fawcett, 1970; Lalli and Clermont, 1981; Oko, 1988) . It has been hypothesized that a component of the perinuclear theca binds and tethers the different membranes of the sperm head (Fouquet et al., 1992; Oko and Maravei, 1994) . The sub-acrosomal layer of the perinuclear theca appears to anchor the acrosomal vesicle to the nuclear membrane; the post-acrosomal sheath of the perinuclear theca is between the PAPM and the nuclear membrane; the outer peri-acrosomal layer of the perinuclear theca links the APM to the outer acrosomal membrane (Oko and Maravei, 1994; Oko et al., 1990) . The major protein present in the perforatorium and associated perinuclear theca, initially named PERF15 (Oko and Clermont, 1988) , was identified as testis lipid-binding protein (TLBP) or fatty acidbinding protein 9 (FABP9) (Oko and Morales, 1994; Schmitt et al., 1994) . The presence of FABP9 in the perinuclear theca has so far been reported for rat and mouse sperm (Korley et al., 1997; Oko and Morales, 1994) .
Fatty acid-binding proteins (FABPs) belong to the conserved multigene family of intracellular lipid-binding proteins (Chmurzynska, 2006) . Ten different FABPs (Fig. 1A ) in several species showing tissuespecific expressions have been characterized: FABP1 (liver; L-FABP), Developmental Biology 348 (2010) [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] FABP2 (intestine; I-FABP), FABP3 (heart; H-FABP), FABP4 (adipocyte; A-FABP), FABP5 (epidermis; E-FABP), FABP6 (ileum; IL-FABP), FABP7 (brain; B-FABP), FABP8 (peripheral nervous system; M-FABP/myelin P2), FABP9 (testis/germ cell; T-FABP) and the newly discovered FABP12 (retina and testis) (Liu et al., 2008; Zimmerman and Veerkamp, 2002) . Transcripts of human homologs for all the FABPs have been sequenced except for FABP9. The different FABPs have a 22-73% sequence similarity with highly conserved three-dimensional structures (Chmurzynska, 2006; Zimmerman and Veerkamp, 2002) . Several functions have been demonstrated for FABPs, including the promotion of cellular uptake of fatty acids (Schurer et al., 1994; Stremmel et al., 1985; Trotter et al., 1996) , intracellular fatty acid trafficking (Falomir-Lockhart et al., 2006; Storch and Thumser, 2000) , fatty acid metabolism (Hotamisligil et al., 1996; Shaughnessy et al., 2000) , signal transduction (Graber et al., 1994; Widstrom et al., 2001) , cell growth (Burton et al., 1994) , differentiation (Aponte, 2002; Borchers et al., 1997; Yang et al., 1994) , and regulation of gene expression (Bernlohr et al., 1997; Wolfrum et al., 2001) . Because of the significant sequence similarity of FABP9 to the membraneassociated FABP8 (myelin P2; 60% sequence homology), which is observed on the cytoplasmic face of the myelin sheath of oligodendrocytes (Eylar et al., 1980; Trapp et al., 1984) , it has been suggested that FABP9 in the perinuclear theca could be the component that tethers the sperm membranes to the perinuclear theca (Oko and Morales, 1994) .
Another functional role for FABP9 in regulating programmed cell death in germ cells has been suggested (Kido and Namiki, 2000) . In their study, FABP9 was shown to localize to germ cells undergoing apoptosis. Supporting this observation, transgenic mice overexpressing FABP9 showed an increase in multinucleate symplasts indicative of apoptosis in elongated spermatids, and a reduction in the number of sperm carrying the transgene (Kido et al., 2005) . However, fertility remained unaffected in these mice. These studies indicate that FABP9 could be involved in several regulatory processes during germ cell development.
Moreover, a recent mass spectrometric study reported that FABP9 was the only protein showing a transition from a completely nonphosphorylated state in non-capacitated sperm to a Ser 3 phosphorylated state in capacitated sperm (Platt et al., 2009) . This also suggested an unknown but functional property of potential importance for FABP9 in mature sperm.
In this study, we examined the functional phenotype resulting from the loss of FABP9 by the targeted disruption of the FABP9 gene in mice. Based on these reports, we hypothesized that defects might be observed in germ cell development, interactions of the cytoskeleton and membranes in the sperm head, and/or capacitation or fertilization. Of interest, our results showed that FABP9 was not absolutely required for successful spermatogenesis and sperm function.
Materials and methods

Reagents and animals
All reagents were purchased from Sigma (St. Louis, MO), unless otherwise noted. Commercial antibodies used were against α-tubulin (Calbiochem, San Diego, CA) and phosphorylated tyrosine (clone 4G10, Millipore, Lake Placid, NY). The EGFP-conjugated domain 4 of perfringolysin O (PFO-D4) used for localizing focal enrichments of sterols was synthesized as described previously . Polyclonal antisera against murine FABP9 were raised in two rabbits at Quality Controlled Biochemicals (Hopkinton, MA) using the antigenic epitope [Ser 40 -Cys 58 ] specific for FABP9. Lipid standards were from Matreya LLC (Pleasant Gap, PA). Pregnant mare serum gonadotropin (PMSG; Calbiochem) and human chorionic gonadotropin (hCG; (FABP8) is the closest relative to FABP9 (60% sequence homology), both diverging from Epidermal-FABP (FABP5). (B) Three dimensional structure for murine FABP9 constructed based on homology to bovine FABP8, satisfying spatial restraints. The structure is comprised of two α-helices and one β-barrel. The beta barrel forms a hydrophobic pocket for accepting/binding lipids. Note the two cysteine residues in one of the α-helices that might play a role in disulfide bonding of FABP9 protein to structural elements (arrowheads in inset). (C) Sequence alignments for mouse, rat and human FABP9 proteins showing conserved amino acids (shaded black). (D) Multiple tissue immunoblot showing specific expression of FABP9 in the testis. Lanes: 1. brain, 2. heart, 3. lung, 4. liver, 5. kidney, 6. spleen, 7. intestine, 8. muscle, 9. ovary, 10. uterus, 11. testis, 12. skin, 13. fat. Calbiochem) were used for superovulation. Mice of the following strains, C57BL/6, 129Sv and B6D2F1 were purchased from the Jackson Laboratories (Bar Harbor, ME).
Protein modeling
Three dimensional homology models for FABP9 were constructed by means of comparative protein structure modeling by satisfying spatial restraints Sali and Blundell, 1993) . Bovine FABP8 [PDB ID: 1pmp; (Cowan et al., 1993) ] and equine FABP8 [PDB ID: 1yiv; (Hunter et al., 2005) ] that had the highest sequence homologies (63.4% and 61.8% respectively) and whose crystal structures were known were used. Structural modeling was carried out using the automated alignment algorithms of Modeller 9v2 (http://www.salilab.org/modeller/) (Eswar et al., 2003; Marti-Renom et al., 2000) to derive a homology-based model. The output was visualized using the graphical interface of PyMOL v1.0 (DeLano Scientific, Palo Alto, CA).
Human FABP9
A human testis large-insert cDNA library (BD Biosciences, Palo Alto, CA) was used to clone and sequence the human FABP9 (hFABP9). Based on results from the NCBI-Gnomon gene prediction method, primers (5′ATGGTTGAGCCCTTCTTGGGAAC and 5′TCACACCTTTTCG-TAGATTCTGGTG) were designed to amplify the putative hFABP9. The resulting PCR product was then cloned using a Topo TA cloning kit (Invitrogen) according to the manufacturer's instructions and was sequenced.
Testicular expression of FABP9
For examining developmental expression of FABP9 in the postnatal testis, samples were collected every two days starting from postnatal day 2 to postnatal day 36 and stored in liquid nitrogen. Testis lysates were prepared by homogenization in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) and protein concentration was estimated using a bicinchoninic acid protein assay kit (Thermo Scientific, Rockford, IL). Equal concentrations of protein (150 μg) from each sample were separated by SDS-PAGE, transferred to PVDF membrane and immunoblotted for the presence of FABP9. For examining spermatogenic stage-specific expression of FABP9, murine testes were decapsulated and incubated in PBS containing 0.75 mg/ml collagenase in a shaking water bath at 33°C for 30 min. The resultant preparation of seminiferous tubules was then washed to remove collagenase and interstitial cells. The separated tubules were visualized under a Nikon SMZ microscope (Melville, NY) and regions containing different stages of the cycle of the seminiferous epithelium (stages I-III, IV-VI, VII-IX and X-XII) were microdissected and collected as described (Kotaja et al., 2004) . Lysates were made by homogenization and boiling in Laemmli sample buffer. Following protein assay, 75 μg of proteins from each segment was separated by SDS-PAGE, transferred to PVDF membrane and immunoblotted for the presence of FABP9.
Sperm collection and handling
Murine sperm were collected from the cauda epididymides by a swim-out procedure as described previously (Travis et al., 2001b) in a modified Whitten's medium [MW; 22 mM HEPES, 1.2 mM MgCl 2 , 100 mM NaCl, 4.7 mM KCl, 1 mM pyruvic acid, 4.8 mM lactic acid hemi-calcium salt, and 5.5 mM D-glucose, pH 7.35 (Travis et al., 2001a) ]. All steps of collection and washing were performed at 37°C, using large orifice pipette tips when handling sperm to minimize membrane damage.
Sperm biochemical fractionation
Membranes from sperm were collected with or without the use of detergents by methods previously described (Travis et al., 2001b) with minor modifications as described below. Sperm (10 × 10 6 cells)
were subjected to 20 bursts of sonication for 10 s each at output 6 using a Branson Sonifier 450 (Branson Ultrasonics Corporation, Danbury, CT) in the presence of 5× protease inhibitors (Roche Applied Science, Indianapolis, IN). Care was taken to avoid frothing and to keep the sample cool. The cell lysate was then centrifuged at 10,000 ×g for 10 min and the supernatant was carefully collected; the remaining coarse pellet of cellular debris formed the P10 fraction. The supernatant was again centrifuged at 100,000 ×g for 1 h. The supernatant (S100 fraction) was carefully separated and the resulting pellet of sperm membrane vesicles formed the P100 fraction. Soluble proteins in the S100 fraction were precipitated using 4% trichloroacetic acid (v/v) followed by neutralization with Tris-buffer. Proteins from the different fractions were boiled in Laemmli sample buffer, separated by SDS-PAGE, transferred to a PVDF membrane and immunoblotted for the presence of FABP9.
Histology and indirect immunofluorescence
Testes fixed in Bouin's solution were processed, embedded in paraffin and sectioned at 4 μm slice thickness. For routine histological examination, sections were stained with hematoxylin and eosin. For localization of FABP9 in testis sections, slides were de-paraffinized, hydrated and then subjected to antigen retrieval in a 0.01 M citrate buffer. Non-specific binding of antibodies was blocked using 5% normal goat serum (NGS), and then samples were incubated with anti-FABP9 antibody (1:100). After incubation, slides were washed in PBS and incubated with an Alexafluor-555-conjugated secondary antibody (1:500). Fluorescent nuclear counterstaining was carried out using Sytox® Green (1 μM final concentration; Invitrogen) for 10 min. Slides were then washed in PBS and mounted using Prolong-Gold mountant (Invitrogen).
For localization of FABP9 in epididymal sperm, cells collected in MW medium were allowed to attach to coverslips and fixed/ permeabilized using either 1:1 acetone:methanol mixture for 60 s at −20°C, or 4% formaldehyde (30 min) and 0.1% TX-100 (2 min). Coverslips were air-dried, rehydrated in PBS and blocked for 30 min with 5% NGS in PBS. Samples were incubated with anti-FABP9 antibody (1:100 dilution). They were then washed with PBS and incubated with Alexafluor-488-conjugated secondary antibody (1:500 dilution). Coverslips were then rinsed and mounted on slides with a GVA-based mountant.
FABP9 targeting construct
Murine bacterial artificial chromosome clone bMQ75a12 (Genome Research Ltd., Wellcome Trust Sanger Institute, Cambridge, UK) containing the 129S7 strain genomic locus of FABP9 was transformed into a recombineering competent strain of bacteria [EL350; (Liu et al., 2003) ]. A 15 kb genomic sequence (~6 kb upstream and downstream of the FABP9 locus) including the FABP9 locus was retrieved into plasmid PL253. PL253 carried a mc1-driven thymidine kinase cassette for negative selection of ES cells. Plasmid PL452 with a neo cassette flanked by loxP sites (loxP-Pgk-em7-Neo-loxP) was used to recombineer and replace exons 1 and 2 of the FABP9 gene in PL253 (Liu et al., 2003) . Bacteria EL350 and plasmids PL253 and PL452 were generous gifts from Neal Copeland, Institute of Molecular and Cellular Biology, Singapore.
Targeting, selection and microinjection of ES cells
TC-1 embryonic stem cells (Deng et al., 1996) were electroporated with SalI-linearized construct and selected in media containing G418 and FIAU as described previously (Weiss et al., 2000) . Genomic DNA from 85 drug-resistant colonies was screened for homologous recombination at the FABP9 locus by Southern blot hybridization after restriction digestion (BamHI) with an external probe [espuF: 5′ CCAGGTCTCAACATTGAGGC; espuR: 5′ CATGTCTAGCTCCAAATCCC], and one correctly targeted clone was identified. This correct targeting of the heterozygous clone was confirmed by performing additional Southern blots using an alternative restriction enzyme digest (PsyI), as well as an internal neo probe. ES cells from this targeted clone were microinjected into C57BL/6 blastocysts and transferred into pseudopregnant C57BL/6 recipients. Three chimeric male mice were identified by their characteristic agouti coat color. They were mated to C57BL/6 females and the germline transmission of the targeted FABP9 allele was determined by coat color of the pups and Southern blot analyses. Crossing heterozygous pairs generated mice homozygous for the targeted FABP9 allele. Mice used for phenotypic analysis were in a 129/B6 mixed background. Inbred 129Sv mice homozygous for FABP9 deletion were also derived to confirm phenotype. Mice were genotyped with primers designed to flank the recombination site to detect deletion of exons 1 and 2 of the FABP9 gene [F9: 5′ AGGTGGGAAAGCCTCTGATT; F9 WT: 5′ AGGCATTCACAACCGAAAAC; F-9 KO: 5′ GCCAGAGGCCACTTGTGTAG].
Phenotypic analysis
Parameters including body weight, testis weights and seminal vesicle weights were measured in 12-week-old mice. Cauda epididymal sperm counts were estimated using a hemocytometer. Breeding trials were conducted to quantify litter sizes from FABP9 −/− × FABP9 −/− vs WT × WT matings. For comparing litter sizes 10 pairs each of WT and KO mice were used; the remainder of the phenotypic analyses were performed with 10-15 mice for each group. Statistical analysis was performed using JMP 8 (SAS Institute, Cary, NC). For the above traits, numeric differences between WT and FABP9 −/− sperm were compared using a t-test (p≤ 0.05 was considered significant).
Sperm abnormalities
Sperm morphology at 400× magnification was evaluated using a dark-field microscope and scored as (a) apparently normal, when morphology appeared unaffected, (b) bent tail, when the flagellum was bent in a hair-pin fashion in the distal midpiece or at the annulus, (c) cytoplasmic droplet, including both proximal and distal droplets of residual cytoplasm, and (d) abnormal head, when there was an obvious defect in sperm head morphology. These evaluations were carried out on least 100 sperm/mouse counting all the sperm in each microscopic field examined. A z-test for proportions was used to compare the mean differences of abnormal sperm populations between WT and FABP9 −/− sperm (p ≤ 0.05 was considered significant). Closer examination of sperm head abnormalities was also carried out using electron microscopy as described below.
Assessment of membrane organization
To label focal enrichments of membrane sterols in live sperm, cells were incubated with PFO-D4 (4 μg/ml) in MW medium for 20 min at 37°C. A stage-mounted incubation chamber (LiveCell, Neue Product Group, Westminster, MD) was used along with an objective heater (Bioptechs, Butler, PA) to maintain sperm at 37°C during imaging. Imaging was performed using a Nikon Eclipse TE 2000-U microscope (Nikon, Melville, NY) equipped with a Photometrics Coolsnap HQ CCD camera (Roper Scientific, Ottobrunn, Germany). Images were captured using Openlab v3.1 software (Improvision, Lexington, MA).
Capacitation-associated protein tyrosine phosphorylation
Incubation with different stimuli for capacitation was carried out with 2 × 10 6 sperm in 300 μl of medium with 5.5 mM glucose under one of two conditions: (a) MW base medium, (b) MW supplemented with 10 mM NaHCO 3 and 3 mM 2-OHCD, for 60 min [shown to support both IVF (Travis et al., 2004) and capacitation-induced tyrosine phosphorylation (Travis et al., 2001a) ]. After incubation, samples were processed for SDS-PAGE, transferred to a PVDF membrane and immunoblotted for phospho-tyrosine residues.
Scanning electron microscopy Sperm collected as described above in MW medium were allowed to attach to silicon chips and fixed using 4% formaldehyde and 0.1% glutaraldehyde in 2.5 mM CaCl 2 in PBS (Selvaraj et al., 2006) for 30 min. Samples were rinsed 5 times in distilled water for 5 min each and then freeze dried. The silicon surface with cells was then sputter coated with gold-palladium. Images were collected using a Zeiss LEO 1550 field emission SEM with a Gemini column (Carl Zeiss Inc., Oberkochen, Germany). A general analysis was first performed to examine the morphology of the sperm heads. A specific morphological analysis for the ventral spur was then performed counting only grossly normal sperm and classified as (a) normal, (b) small, or (c) absent for at least 50 sperm/mouse. A z-test for proportions was used to compare the mean differences of ventral spur morphologies between WT and FABP9 −/− sperm (p ≤ 0.05 was considered significant).
Transmission electron microscopy
Sperm samples were prepared by fixing sperm in suspension with 2% glutaraldehyde and 4% tannic acid in a phosphate buffer (pH 7.0-7.5) for 4 to 6 h at room temperature. Samples were then washed overnight in a 0.1 M sodium cacodylate buffer (pH 7.4) with 7% sucrose at room temperature. They were then fixed for 2 h with 1% OsO 4 with 5% sucrose in 0.1 M sodium cacodylate at 4°C. They were treated with 0.5% uranyl acetate containing 4% sucrose for 1 h at room temperature. Samples were then quickly dehydrated and embedded in epoxy resin. Thin sections were collected on Formvar-carboncoated nickel grids and stained with 5% aqueous uranyl acetate followed by alkaline lead. Images were then collected using a transmission electron microscope (Philips Tecnai 12 BioTwin, FEI Company, Hillsboro, OR).
In vitro fertilization and sperm competition TYH medium [118.8 mM NaCl, 4.78 mM KCl, 1.19 mM KH 2 PO 4 , 1.19 mM MgSO 4 •7H 2 O, 25 mM NaHCO 3 , 1.71 mM CaCl 2 •2H 2 O, 5.56 mM D-glucose, 1.01 mM Na-pyruvate, 29.2 mM Na-lactate, 4 mg/ml BSA, 0.05 mg/ml Streptomycin sulfate, and 100 IU/ml Penicillin-G potassium: pH 7.4 (Toyoda et al., 1971) ] pre-equilibrated in 5% CO 2 at 37°C for 12 h (pH 7.4) was used for the in vitro fertilization trials. Nineteen-day-old B6D2F1 female mice were superovulated by intra-peritoneal injections of PMSG (5 IU) followed after 48 h by hCG (5 IU) (Runner and Gates, 1954) . The females were euthanized 13 h after hCG injection and oocytes were collected from the oviduct into TYH medium as a droplet under mineral oil (Sydney IVF culture oil, Cook Medical, Bloomington, IN) in a Petri dish. One hour before euthanasia of female mice, sperm from the cauda epididymides were collected from the required males in TYH medium. Sperm were allowed to capacitate at 37°C in a 5% CO 2 incubator until oocyte collection. Sperm concentration for each sample was then quantified and sperm were added to the fertilization droplet to attain a final concentration of 1 million sperm/ml (final volume 100 μl). For sperm competition assays either equal number of sperm (1:1) from
FABP9
−/− and WT were introduced into the same fertilization droplet or proportions of 1:4 and 4:1 were used; the final sperm concentration was kept constant at 1 million/ml. The dish was then incubated in a chamber with an atmosphere of 5% O 2 , 5% CO 2 and 90% N 2 at 37°C. After 5 h, eggs were rinsed briefly in fresh TYH medium and transferred to KSOM medium [95 mM NaCl, 2.5 mM KCl, 0.35 mM KH 2 PO 4 , 0.2 mM MgSO 4 , 1.71 mM CaCl 2 , 25 mM NaHCO 3 , 10 mM Nalactate, 0.2 mM D-glucose, 0.2 mM Na-pyruvate, 1 mM glutamine, 0.01 mM EDTA, 1 mg/ml BSA, 1 ml MEM essential amino acids, 0.5 ml MEM non-essential amino acids, 0.05 mg/ml Streptomycin sulfate, and 100 IU/ml Penicillin-G potassium; pH 7.4 (Erbach et al., 1994) ] for embryo development. Embryo development to a 4-cell stage was considered as the endpoint for successful fertilization. Embryos derived from sperm competition experiments were treated with 0.5% Pronase (Roche Applied Science, Indianapolis, IN) in TYH medium for 5 min to remove any surface adherent sperm and subsequently genotyped to determine the performance of FABP9
−/− sperm.
Total lipid extraction and thin layer chromatography
Total lipids were extracted from sperm from 3 mice using the Folch method (Folch et al., 1957) . For thin layer chromatography (TLC), lipid extracts were reconstituted in 60:25:4 (chloroform:methanol:water) and spotted on a silica gel 60 plate (Merck, Damstadt, Germany) along with lipid standards and developed with the 60:25:4 solvent system (Wedgwood et al., 1974) . Fluorescent bands were imaged after spraying with a primuline solution [0.005% (w/v) primuline in 80% (v/v) acetone; (Wright, 1971) ] and excitation using UV-wavelength transillumination.
Fatty acid mass spectrometry
Total lipids were extracted from 12 × 10 7 sperm using the Bligh and Dyer (1959) method. Fatty acid methyl esters (FAME) were prepared using sodium hydroxide followed by esterification with boron-trifluoride (BF 3 ) in methanol, and were analyzed by gas chromatography (HP 5890; BPX-70 column, SGE, Austin, TX), using H 2 carrier gas as described previously (Sarkadi-Nagy et al., 2003) . FA identities were determined by covalent adduct chemical ionization tandem mass spectrometry (Lawrence and Brenna, 2006; Van Pelt and Brenna, 1999) and the quantitative profiles were calculated using methyl-17:0 as an internal standard. The results were calibrated using response factors derived from an equal weight FAME mixture. FA concentrations were expressed as percentage weight of total FA from 14 to 22 carbons. A t-test was used to compare quantitative differences of individual lipid species between WT and FABP9 −/− sperm.
Results
Structural features and expression of FABP9
FABP9 is the most abundant protein of the perinuclear theca and perforatorium of murine sperm. It shares significant sequence homologies with different members of the FABP family (Fig. 1A) . Comparing nucleotide substitutions, murine FABP9 is closely related to FABP8/Myelin P2. Based on its 3D homology model, we find that FABP9 shares the conserved features of all other FABPs. It has two α-helices capping an anti-parallel β-sheet that forms a barrel (Fig. 1B) . The lipid-binding site is formed by the hydrophobic concavity within the β-barrel. The N-terminal tail formed by a conserved Phe 5 residue forms a characteristic lid for the hydrophobic core. One unique feature of murine FABP9 compared to other FABPs was the presence of two cysteine residues (Cys 28 and Cys 35 ) in helix-2 (Fig. 1B-arrowheads in  inset) . These cysteine side chains are present on the surface of the protein away from the opening of the hydrophobic core giving it the potential ability to form disulfide bonds with structural elements in sperm without affecting its lipid-binding property.
Primers designed for the predicted human FABP9 gave a product at the expected length (~400 bp). On sequencing, this product yielded a sequence homologous to known sequences of mouse and rat FABP9. The sequence mapped to a locus in human chromosome 8. On comparing amino acid sequences, human FABP9 showed 71% homology to mouse and 66% homology to rat FABP9 (Fig. 1C) . The two cysteine residues in helix-2 in mouse and rat FABP9 were not conserved in the human FABP9 sequence. Immunoblots of various murine tissues showed the testis-specific expression of FABP9 (Fig. 1D) .
Developmental expression and biochemical characterization of FABP9
During postnatal testicular development, FABP9 expression started from day-16 consistent with the appearance of late pachytene spermatocytes ( Fig. 2A) (Bellve et al., 1977) . On dissected seminiferous tubules, FABP9 expression was more abundant in stages containing germ cells in advanced stages of spermiogenesis (Fig. 2B) .
Biochemical fractionation of FABP9 showed that unlike other FABPs, FABP9 was not soluble but was strongly associated with structural elements in mature sperm (Fig. 2C ). This association was not disrupted by vigorous sonication, but a small fraction of FABP9 could be solubilized using TX-100. The same experiment was also performed using isolated germ cells with similar results (data not shown) suggesting that FABP9 predominantly exists in association with cytoskeletal structures even during early developmental events during spermatogenesis, consistent with its localization to the perinuclear theca and the perforatorium.
Generation and phenotypic analysis of FABP9
−/− mice To explore potential roles of FABP9 in spermatogenesis, sperm structure and membrane organization, and fertilization, we generated mutant mice that lacked FABP9 by a targeted deletion achieved by homologous recombination in embryonic stem cells. The targeting construct was designed to replace~2.7 kb of the FABP9 locus including exons 1 and 2 and a large part of the promoter region (Fig. 3A) . In addition to preventing transcription of this locus, this would disrupt the synthesis of the entire FABP9 protein (132 amino acids). The genotypes of targeted embryonic stem cell clones were screened by Southern blot analysis of genomic DNA (Fig. 3B ) and one heterozygous (FABP9 +/− ) clone was identified. Genomic DNA from mice generated from transmitting chimeras was also screened using Southern blot analysis and genotyping PCR (Fig. 3C) . Mating between heterozygous F1 siblings was set up to derive homozygous mice (FABP9
−/−
). RT-PCR analysis indicated the absence of FABP9 mRNA in the FABP9 −/− testis (Fig. 3D ). In addition, protein extracts of FABP9 −/− testis completely lacked the 15-kDa protein corresponding to FABP9 (Fig. 3E) (Fig. 4B) . Both male and female FABP9 −/− mice were fertile and produced litter sizes (6.9 ± 0.4 pups/litter) equivalent to those of WT mice (7.2 ± 0.3 pups/litter; Fig. 4C ). Seminal vesicle weights were not different between FABP9 −/− and WT mice (Fig. 4D) . With sonication, FABP9 was found only in the P10 fraction that represents insoluble cytoskeletal structures and organelles. With TX-100, FABP9 was also seen predominantly in the P10 fraction although a small percentage solubilized and was found in the S100 fraction. FABP9 did not associate with the P100/membrane fraction.
Spermatogenesis in FABP9 −/− mice
Immunofluorescence labeling of FABP9 was observed in advanced stages of germ cell development. FABP9 protein expression appeared to be particularly pronounced in elongating spermatids and more mature testicular germ cells (Fig. 5A) . FABP9 was localized in part to the cytoplasm in elongating spermatids, and it was also expressed abundantly in certain rare spermatocytes (arrowheads, Fig. 5A ). Germ cell development was unaffected in FABP9
−/− testes and we did not detect any pathology associated with germ cells or the seminiferous epithelium. Immunofluorescence localization confirmed the absence of FABP9 in the knockout testes (Fig. 5B) . However, non-specific labeling by the polyclonal antibody was seen in the principal piece of the developing sperm in tubules containing advanced stages of spermiogenesis (arrowheads; Fig. 5B ). In cauda epididymal wild type sperm, the perforatorium was more intensely labeled with FABP9 with a weaker signal detected in the post-acrosomal region of the perinuclear theca (Fig. 5C ). This was seen only after acetone:methanol fixation and permeabilization suggesting a deep-seated association between FABP9 and these structures. We also detected the nonspecific labeling of the principal piece as seen in testicular sperm (not shown).
Comparison of sperm morphology between FABP9 −/− and WT mice revealed significant but modest differences in numbers of abnormal heads in FABP9 −/− sperm (3.88 ± 0.54% in WT vs 11.88 ± 1.81% in FABP9 −/− sperm; Fig. 6A ; p = 0.05). Sperm head abnormalities included misshaped apical parts of the sperm head and more severe shape distortions involving both apical and distal parts of the head (Figs. 6B, C and D) . At the ultrastructural level, significantly higher numbers of FABP9 −/− sperm were also found to completely lack a morphological feature of the sperm head called the ventral spur (0% in WT vs 10.7 ± 1.3% in FABP9 −/− sperm; Fig. 7A ; p = 0.004).
Representative SEMs of a WT sperm head showing normal ventral spur morphology and a FABP9 −/− sperm head that is lacking a ventral spur are shown (Fig. 6B) .
Sperm membrane organization and sperm capacitation in FABP9
−/− mice To investigate whether FABP9 was responsible for tethering membrane components to the perinuclear theca, we examined the ultrastructural organization of the perforatorium, perinuclear theca and associated membranes in WT and FABP9 −/− sperm. From the sections obtained, although we could not examine the dense mass of perforatorial material and the rods that form the perforatorium, we did not find any difference in structural contours between FABP9
−/− compared to WT sperm heads (Figs. 8A and B) . Transmission electron micrographs (TEMs) also showed normal membrane ultrastructure, with the plasma membrane positioned in close apposition to the underlying acrosome and perinuclear theca of the sperm head and fibrous sheath of the sperm tail in FABP9 −/− sperm (Figs. 8C, D and E).
To examine lipid distribution in addition to membrane tethering, we localized G M1 and focal enrichments of membrane sterols to evaluate the known micron-scale lipid segregation in the plasma membrane of the sperm head. Sperm from FABP9 −/− mice did not show any defects in the segregation of G M1 and enrichments of sterols in the plasma membrane overlying the acrosome (Figs. 9A and B respectively). We also investigated the capability of FABP9 −/− sperm to respond to stimuli for capacitation by evaluating the capacitationassociated protein tyrosine phosphorylation profile. Sperm from FABP9 −/− mice showed a normal response to bicarbonate ions and 2-OHCD in the medium and displayed hyperactivated motility (data not shown) and a normal profile of tyrosine phosphorylated proteins (Fig. 9C) as seen in capacitated sperm.
In vitro fertilization performance of FABP9 −/− sperm Our breeding data showed no differences between WT and FABP9 −/− males in fertility or litter size. However, in natural matings, ejaculated sperm are exposed to significant lipid modifications as a result of exposure to seminal plasma and the uterine and oviductal fluids. These modifications might compensate for or rescue specific lipid deficits and thereby mask possible functional phenotypes in FABP9 −/− sperm.
Therefore, we examined the functional ability of epididymal FABP9
−/− quantiles; the median is represented as a horizontal line within the box, and the mean as a horizontal line through the box. Vertical whiskers extend from the ends of the box to the 10th and 90th quantiles. Comparisons for: (A) testis weights, (B) cauda epididymal sperm counts, (C) litter sizes and (D) seminal vesicle weights are shown (n = 9-11/group). For these comparisons, 12-week-old FABP9 −/− and WT mice were used for sperm counts and other morphometric parameters; litter sizes were obtained from breeding trials. sperm to fertilize oocytes in vitro. In vitro fertilization (IVF) trials were carried out using FABP9 −/− and WT sperm either separately or in competition with each other. Our results showed no significant differences in overall fertilization rates when FABP9 −/− and WT sperm were used separately (Table 1) . When sperm were used in competition, the numbers of WT and FABP +/− embryos obtained were 9:8 for equal sperm proportions (1WT:1KO; n = 2), 6:23 when used at 1WT:4KO (n= 2) and 19:1 when used at 4WT:1KO (n= 2). These data confirmed that FABP −/− sperm did not exhibit any significant deficits in fertilizing mature oocytes in vitro.
Lipid profiles of FABP9 −/− sperm To investigate whether the deficiency of FABP9 led to changes in sperm lipids, we analyzed total lipids and performed a detailed analysis of fatty acids in WT and FABP9 −/− sperm. Based on phospholipid, sphingolipid and fatty acid standards, several classes of lipids were observed in the analysis of total lipids using TLC.
Comparison of relative profiles of total lipids did not show any detectable differences between WT and FABP9 −/− sperm (Fig. 10A ).
Specific analysis for fatty acids using covalent adduct chemical that the two views are slightly oblique to one another, but both show the apical acrosome extending up the convex curve, both show the extension of the nucleus into the hook, and both show normal tethering of the acrosome to the underlying structure and normal tethering of the plasma membrane overlying the acrosome. Sperm ultrastructure and membrane tethering were also normal in null sperm in the equatorial region (C), the post-acrosomal region (D), as well as the principal piece (E). Black arrows point to the bilayer structure of the plasma membrane. [N: nucleus; Ac: acrosome; Ax: axoneme; Fs: fibrous sheath]. Fig. 9 . Membrane organization and signaling in FABP9 −/− mice. Localization in FABP9 −/− sperm of (A) glycosphingolipid G M1 and (B) focal enrichments of membrane sterols. EGFPconjugated D4 of perfringolysin O (PFO-D4) was used to localize focal enrichments of sterols and CTB was used to localize G M1 . These segregations to the plasma membrane overlying the acrosome were consistent both with previous reports (Selvaraj et al., 2006 [NC: non-capacitated; C: capacitated].
ionization tandem mass spectrometry detected 14:0, 16:0, 18:0, 18:1n-9, 18:2n-6, 20:3n-6, 20:4n-6, 22:5n-3 and 22:6n-3 (Fig. 10B ).
Discussion
In both mouse and rat sperm, previous studies have shown that FABP9 is the major protein of the perforatorium and perinuclear theca (Korley et al., 1997; Oko and Morales, 1994) . Therefore, FABP9 has been suggested to be a critical building block in the organization of the perinuclear theca and attachment of sperm plasma membrane to those underlying structures. However, both the assembly and functions of sperm ultrastructural elements such as the perinuclear theca and perforatorium are inadequately understood. The facts that FABP9 is a testis-specific member of this family of proteins and that it is phosphorylated during capacitation further suggested to us the likely importance of FABP9 in spermatogenesis and/or the function of mature sperm.
Phylogenetic analysis indicates that FABP9 potentially evolved from a gene duplication event along with FABP4, FABP5 and FABP8 (Karanth et al., 2008) . Despite the high level of homology shared by FABPs, sequence analysis of FABP9 showed unique elements not present in other FABPs. Two cysteine residues (Cys 28 and Cys 35 ) were found to be unique in mouse and rat FABP9. Formation of disulfide bonds by these conserved residues could mark an important functional transition in this FABP from being a soluble transport protein to an anchored lipid tethering protein. It is also well known that disulfide bonds play critical roles in the organization of the sperm head perinuclear theca (Calvin and Bedford, 1971) , suggesting that it might anchor sperm membranes to this underlying support. Our biochemical characterization of murine FABP9 supported this theory by showing that FABP9 was not soluble but instead was tethered to cytoskeletal elements in sperm, such as the perinuclear theca and rods of the perforatorium. Of interest, we found that FABP9 was transcribed in human testis although human sperm heads are spatulate in shape. Sequence for the human FABP9 transcript did not contain the two cysteine residues as seen in the mouse suggesting that there could be inter-species differences in functional characteristics of this protein. However, protein expression and localization of FABP9 in either human sperm or other testicular cells remain to be determined.
In the mouse, FABP9 protein was detected as early as day-16 of testicular development but prominent expression was visualized only in late elongating spermatids. This expression pattern of FABP9 late during spermiogenesis strongly suggested its involvement in a terminal differentiation process after the acrosome and sub-acrosomal layer have already capped the nucleus. We also observed rare and sporadic FABP9 expression in some spermatocytes that could indicate apoptotic cells (Kido and Namiki, 2000) . Unexpectedly, the lack of FABP9 did not have a significant effect on the apoptotic regulation of germ cell numbers during spermatogenesis as had been suggested (Kido et al., 2005) .
In addition to a lack of observable change in spermatogenesis, sperm from FABP9 −/− mice did not show any functional deficits compared to WT sperm at a population level. Membrane lipid organization and attachment were not affected by the loss of FABP9 suggesting that FABP9 is not essential for the compartmentalization of membrane domains in sperm. Moreover, structural features of the sperm head including the perforatorium were also not outwardly affected in FABP9 −/− sperm at the level of SEM as had been predicted by previous studies (Korley et al., 1997; Oko and Morales, 1994) . Although this is an unexpected observation as FABP9 has been reported to be the major protein in these structures, it can be explained by previous studies that identify other cytoskeletal elements in the sperm head also associated with both the perinuclear theca and perforatorium (Aul and Oko, 2002; Longo et al., 1987; Oko and Morales, 1994) . However, we note that we were not able to make a fine comparison at the TEM level between WT and FABP9 −/− sperm regarding the internal organization of the perforatorium, that might not be reflected outwardly at the SEM level. a Determined based on the number of 4-cell embryos in culture. (1) Polar lipid mix: cholesterol, phosphatidyl ethanolamine, lecithin, lyso-lecithin; (2) Sphingolipid mix: cerebrosides, sulfatides, sphingomyelin; (3) Fatty acid mix: methyl palmitate, methyl stearate, methyl oleate-9, methyl linoleate-9,12, methyl linoleate-9,12,15; (4) Poly-unsaturated fatty acid (PUFA) mix: C14, C16, C16:1n-7, C18:1n-7, C18:1n-9, C18:2n-6, C20:1n-9, C18:4n-3, C22:1n-11, C20:5n-3, C22:1n-9, C22:5n-3, C22:6n-3. Fluorescent bands were imaged after spraying with a primuline solution. (B) Quantitative profiles of sperm fatty acids were determined by covalent adduct chemical ionization tandem mass spectrometry and calculated using methyl-17:0 as an internal standard. Detectable fatty acids were 14:0, 16:0, 18:0, 18:1n-9, 18:2n-6, 20:3n-6, 20:4n-6, 22:5n-3 and 22:6n-3. There were no significant differences in fatty acid levels between WT and FABP9 −/− sperm.
Functionally, FABP9 −/− sperm performed on par with WT sperm in assays for in vivo fertility, in vitro capacitation and IVF suggesting that the Ser 3 phosphorylation of FABP9 that occurs during capacitation (Platt et al., 2009 ), is also not essential. Finally, the loss of FABP9 did not generate differences in total lipid or fatty acid profiles suggesting that membrane lipid and fatty acid production, transport and metabolism were not affected in FABP9 −/− germ cells during spermatogenesis. One possible explanation for this lack of difference is compensation by a functionally redundant protein. Recent studies have discovered another member of the FABP family of proteins that are expressed in germ cells. This newly identified FABP12 does not share Cys 28 but contains the Cys 35 residue. However, a compensatory role for this protein is speculative because FABP12 transcripts have a distinct developmental expression pattern and only a 55% sequence homology to FABP9 (Liu et al., 2008) . Alternatively, transfer of proteins or lipids from Sertoli cells to germ cells during spermatogenesis could compensate for the lack of FABP9.
Although reproductive functions in FABP9 −/− mice were unaffected, the null males did have a higher rate (~8% increase compared to WT sperm) of sperm head abnormalities. Moreover, ultrastructural examination of FABP9 −/− sperm showed that the ventral spur was absent in a significant but modest proportion of sperm (~10% of FABP9 −/− sperm compared to none in WT sperm). The ventral spur is formed by an extension of the sperm head cytoskeleton surrounded by the post-acrosomal dense lamina (Oko and Clermont, 1988) . In sperm from Australian hydromyine rodents, which have a very pronounced ventral spur that is easy to isolate, it has been shown that FABP9 is the dominant protein in this structure (Breed et al., 2000) . Therefore, underdevelopment of this structure can reasonably be correlated with the loss of FABP9. From an evolutionary perspective, the tremendous variations observed in sperm head morphology among species of rodent are highly noteworthy. For example, several species of wild murid rodents from southern Asia and Australia have spatulate or globular heads (Breed, 1993 (Breed, , 1997 . Given this morphological diversity among fertile rodent species, it is perhaps not unreasonable to speculate that a structural deficit such as absence of the ventral spur in FABP9 −/− sperm would not affect fertility;
however, it must be acknowledged that the fertilizing ability of "spur-less" sperm was not directly evaluated in our studies. It is possible that morphologically normal sperm that formed the major population overshadowed the deficits, if any, of the "spur-less" sperm in our functional assays. In summary, the present study tests several hypotheses related to FABP9 function that have existed since the first description of this protein some decades ago. We report surprising findings that several of the prominent roles suggested for FABP9 were minimally affected in FABP9 −/− sperm. Although there were higher rates (~8% compared to WT sperm) of structural defects of the FABP9 −/− sperm head, and a proportion (~10%) of FABP9 −/− sperm specifically lacked the ventral spur, many FABP9 −/− sperm remained morphologically normal suggesting that FABP9 only played a minor role in the development and function of sperm. These findings highlight our lack of knowledge of how sperm are formed and reinforce the concept of functional redundancy at multiple levels in spermatogenesis and mature sperm.
